Recall Ledger

Carbamazepine Tablets recall (Golden State Medical Supply Inc.)

DrugClass IIOngoing

Summary: Golden State Medical Supply Inc. is recalling Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA. Reason: CGMP deviations: tablets with black specks.

What is being recalled

Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA

Why

CGMP deviations: tablets with black specks.

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

USA Nationwide

How to tell if yours is affected

Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0771-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedAugust 7, 2026
ReportedAugust 26, 2026
CompanyGolden State Medical Supply Inc.
Company locationCamarillo, CA, United States
Initiated byVoluntary: Firm initiated
Quantity1200 bottles

More recalls from Golden State Medical Supply Inc. · all drug recalls · recalls from August 2026

Official FDA record